SELECTA BIOSCIENCES, INC.

$80$125

Selecta Biosciences is a clinical-stage biopharmaceutical company which is using ImmTOR platform, specially designed for induction of tolerance to novel biologic therapies that would otherwise be limited by immunogenicity with the goal of safely and effectively treating serious and rare diseases. The company is engaged to develop products for many such diseases are treated with biologic therapies that are foreign to the patient’s immune system and therefore elicit an undesired immune response.

Report ID:

UMHE21214

Published:

Jan-2022

Pages:

12

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMCG21212 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Value
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    SWOT Analysis
8.    Key Financials
9. Recent Developments
9.1 Product Launches
9.2 Partnerships”

Companies Mentioned

Asklepios BioPharmaceutical, Inc.